Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?

Publikation: AndetUdgivelser på nettet - Net-publikationFormidling

Standard

Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach? / Wested, Jakob; Minssen, Timo; Van Zimmeren, Esther .

Harvard Law School's Bill of Health blog. 2018Blog post.

Publikation: AndetUdgivelser på nettet - Net-publikationFormidling

Harvard

Wested, J, Minssen, T & Van Zimmeren, E 2018, Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?. Harvard Law School's Bill of Health blog. <http://blogs.harvard.edu/billofhealth/2018/07/14/will-the-epos-enlarged-board-of-appeal-step-into-the-crispr-patent-battle-and-reconsider-the-all-applicants-approach/>

APA

Wested, J., Minssen, T., & Van Zimmeren, E. (2018, jul). Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach? Harvard Law School's Bill of Health blog. http://blogs.harvard.edu/billofhealth/2018/07/14/will-the-epos-enlarged-board-of-appeal-step-into-the-crispr-patent-battle-and-reconsider-the-all-applicants-approach/

Vancouver

Wested J, Minssen T, Van Zimmeren E. Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach? 2018.

Author

Wested, Jakob ; Minssen, Timo ; Van Zimmeren, Esther . / Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?. 2018. Harvard Law School's Bill of Health blog.

Bibtex

@misc{b8ac9679f4cc4727b90b0f3a3c63c2e6,
title = "Might the EPO{\textquoteright}s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?",
abstract = "The Broad Institute is facing a formidable task in defending the revoked CRISPR patent claims in their pending appeal at the EPO. Ultimately, some of the issues might still be referred to the Enlarged Board of Appeal. However, this might require a significant amount of legal and rhetorical agility.",
author = "Jakob Wested and Timo Minssen and {Van Zimmeren}, Esther",
year = "2018",
month = jul,
language = "English",
publisher = "Harvard Law School's Bill of Health blog",
type = "Other",

}

RIS

TY - ICOMM

T1 - Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?

AU - Wested, Jakob

AU - Minssen, Timo

AU - Van Zimmeren, Esther

PY - 2018/7

Y1 - 2018/7

N2 - The Broad Institute is facing a formidable task in defending the revoked CRISPR patent claims in their pending appeal at the EPO. Ultimately, some of the issues might still be referred to the Enlarged Board of Appeal. However, this might require a significant amount of legal and rhetorical agility.

AB - The Broad Institute is facing a formidable task in defending the revoked CRISPR patent claims in their pending appeal at the EPO. Ultimately, some of the issues might still be referred to the Enlarged Board of Appeal. However, this might require a significant amount of legal and rhetorical agility.

M3 - Net publication - Internet publication

PB - Harvard Law School's Bill of Health blog

ER -

ID: 199590381